Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

ABSTRACT:

SUBMITTER: Afolabi MO 

PROVIDER: S-EPMC7613317 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature